Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.

Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.

Item
http://www.wikidata.org/entity/Q36812669
PCSK9 and Atherosclerosis - Lipids and Beyond.Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering.PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans.Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia.Accelerated atherosclerosis development in C57Bl6 mice by overexpressing AAV-mediated PCSK9 and partial carotid ligation.Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.Proprotein Convertase Subtilisin/Kexin 9 Levels in Relation to Systemic Immune Activation and Subclinical Coronary Plaque in HIV.Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables.Editorial highlights from Cardiovascular Research.Peripheral vascular atherosclerosis in a novel PCSK9 gain-of-function mutant Ossabaw miniature pig model.Clinical and translational science in cardiovascular research: highlights from the American Heart Association Scientific Sessions 2017: Changing view on the concept of cardiovascular risk and blood pressure targets.Non-Native Conformational Isomers of the Catalytic Domain of PCSK9 Induce an Immune Response, Reduce Lipids and Increase LDL Receptor Levels.
P2860

Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.

Item
http://www.wikidata.org/entity/Q36812669
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Human PCSK9 promotes hepatic l ...... and LDLR-mediated mechanisms.
@ast
Human PCSK9 promotes hepatic l ...... and LDLR-mediated mechanisms.
@en
type
label
Human PCSK9 promotes hepatic l ...... and LDLR-mediated mechanisms.
@ast
Human PCSK9 promotes hepatic l ...... and LDLR-mediated mechanisms.
@en
prefLabel
Human PCSK9 promotes hepatic l ...... and LDLR-mediated mechanisms.
@ast
Human PCSK9 promotes hepatic l ...... and LDLR-mediated mechanisms.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Human PCSK9 promotes hepatic l ...... - and LDLR-mediated mechanisms
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932